CPD-002
CPD-002 is an inhibitor for vascular endothelial growth factor receptor 2 (VEGFR 2), that inhibits angiogenesis through inhibition of VEGFR2/PI3K/AKT signaling pathway. CPD-002 exhibits anti-inflammatory activity and attenuates rheumatoid arthritis[1].
Product Specifications
CAS Number
2617376-08-4
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cpd-002.html
Solubility
10 mM in DMSO
Smiles
CNC(C1=CC=CC=C1SC2=CC3=C(C(NC(C)=O)=NN3)C=C2)=O
Molecular Formula
C17H16N4O2S
Molecular Weight
340.40
References & Citations
[1]Jiang F, et al., CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway. Int Immunopharmacol. 2024 Apr 20;131:111850.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036435-AP 200 µL
HAUS3, ID (HAUS3, C4orf15, HAUS augmin-like complex subunit 3) (AP) discontinued
Sign In for Pricing
View Details 
TRV-0029838 96 Tests
Multiplex Assay Kit for Lipase A, Lysosomal Acid (LIPA), etc. by FLIA (Flow Luminescence Immunoassay)
Sign In for Pricing
View Details